For instance, it may become possible to increase the likelihood of direct religious experience – i.e. 'revelation': the subjective experience of communication from the deity.
By understanding the mechanism of drug resistance and discovering novel targets for pharmacological, molecular, and genetic intervention, it may become possible to increase the usefulness of existing anti-cancer drugs.
Within 6 years (2006 2012), it became possible to increase the number of teams, starting with one team in 2006 and having nine teams since 2012.
As the amount of available genome-scale data has continued to increase, it has become possible to ask higher level questions about the systems-level functional associations between entire pathways and processes.
This approach has already been used to characterize the genomes of uncultivated microbes (Marcy et al., 2007; Woyke et al., 2009) and as the throughput of the associated technologies increase it should become possible to obtain high-resolution profiles of populations or communities.
Once such processes are understood, it might become possible to exploit the properties of altered zones in order to increase the reservoir performance, while mitigating perceptible seismicity.
Given the highly reproducible results that we observed in the different input-Seq experiments, as more ChIP-Seq input controls for the same species become available, it will become possible to detect chromatin differences at specific loci with increasing resolution.
Owing to the creation and application of analytical procedures, methods, and instruments of increasing sophistication, it has become possible to identify and determine ever-decreasing amounts of analytes in various forms and of various levels of threat to our environment.
As the number of annotated fungal genes in databases like GenBank increases, it should become possible to determine which fungi or ecological groups (e.g. ectomycorrhizal vs. saprotrophic basidiomycetes vs. saprotrophic ascomycetes) are most important in soil cycling processes.
As the numbers of patients treated with targeted agents increases, it will become possible to determine whether significant tumour dependency exists for a specific biological target, at least in a subset of patients.
With this increasing body of data, it has now become possible to analyze different structural and functional aspects of those LDV genomes.
